Shareholder

1. On what stock exchange is Toxin Alert listed?
Shares of Toxin Alert trade on the TSX Venture Exchange (CDNX) under the symbol YTX.

2. What are the company's plans to list on other exchanges?
Toxin Alert does not have plans to list on other exchanges in the near future. However, the company does explore from time to time the advantages of listing on a senior exchange and will consider

3. When will Toxin Alert become RRSP eligible?
Since its IPO, Toxin Alert has been an RRSP-eligible investment. It is a Canadian company and may qualify as foreign content for US investors; please consult an investment advisor.

4. Who are the company's independent auditors?
KPMG LLP, Chartered Accountants have audited the financial statements of the company since December 2000.

5. Who is the Toxin Alert's legal counsel?
McCarthy Tétrault LLP is the company's legal counsel.

6. Does the company pay a dividend?
Toxin Alert does not pay a dividend. The company's policy is to reinvest earnings, when available, in expansion.

7. Has Toxin Alert considered a share consolidation?
No, the company has not considered such a decision. The Board of Directors may vote to split or consolidate the stock from time to time, after a period of significant price appreciation or depreciation. Such a decision would be communicated to all shareholders.

8. When was the company' initial public offering? What was the subscription/opening price?
Toxin Alert's initial public offering was concluded on December 15, 1999 and shares in the company began trading at $3.00 on February 7, 2000.

9. Does Toxin Alert have plans for another public offering?
The company believes that has sufficient cash resources for continued operations into Fiscal 2003. Income sources, such as supply contracts and research grants, support Toxin Alert's research and development initiatives. Revenue is expected from the commercialization of Toxin Guard in calendar 2002.

10. Does Toxin Alert have a direct stock purchase plan?
Canadian regulations do not allow Canadian companies, such as Toxin Alert, to offer direct stock purchases. Canadian securities commissions currently are reviewing this policy and Toxin Alert will advise shareholders if the regulations change. Until then, purchases can be made through a stockbroker.

11. How do I sell or transfer ownership of my stock or obtain or change information about my account?
We recommend that you make initial requests through a broker. Should you require additional information or assistance, please contact our transfer agent and registrar, Equity Transfer Services of Toronto, at [(416) 361-0152 or info@equitytransfer.com].

12. What are the exercise terms of the company's Class A Warrants?
Prior to its initial public offering, Toxin Alert issued two sets of special warrants in connection with private placements to fund its growth. The Class A warrants may be exercised for one common share at $4.50 apiece on or before March 31, 2002.

13. How can I obtain a copy of Toxin Alert's annual report?
Reports are available in the investor relations section of this website. If you would like to request a hard copy, please complete the investor request form or send an email to kdimatteo@toxinalert.com.